Desmoid Tumors: all 71 studies
Page 1 of 1. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- Patient-reported Outcomes Following Percutaneous Ablation of Desmoid TumorsEnrolling by invitationNCT07755176
- A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).Not yet recruitingNCT07729371Phase 1
- A Study in Adults With Desmoid TumorsRecruitingNCT07541430Phase 2
- Immunological Phenotype of Desmoid-fibromatosis-affected Patients.RecruitingNCT07496242
- Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)RecruitingNCT07176689Phase 4
- Treatment of Desmoid Fibromatosis With Arterial EmbolizationRecruitingNCT06945887
- A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid TumorsNot yet recruitingNCT06355921Not applicable
- Arterial Chemoembolization for the Treatment of Desmoid FibromatosisRecruitingNCT06268457
- Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After CryoablationRecruitingNCT06224283
- Clinicopathological Features and Molecular Typing of Invasive Fibroma of Abdominal WallRecruitingNCT06204198
- Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingRecruitingNCT06081400Not applicable
- Study of Cryoablation and Nirogacestat for Desmoid TumorRecruitingNCT05949099Phase 2
- FOG-001 in Locally Advanced or Metastatic Solid TumorsRecruitingNCT05919264Phase 1/2
- Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid TumorRecruitingNCT05490667Not applicable
- HIFU Ablation of Soft Tissue SarcomaRecruitingNCT05111964Not applicable
- Cryotherapy in the Treatment of Desmoid TumorsRecruitingNCT05091255Not applicable
- Individual Patient Compassionate Use of NirogacestatAvailableNCT05041036
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruitingNCT04851119Phase 1/2
- Observing People With Desmoid-Type FibromatosisRecruitingNCT04281381
- Project: Every Child for Younger Patients With CancerRecruitingNCT02402244
- Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids TumorsRecruitingNCT01898416Phase 2
- Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)CompletedNCT03785964Phase 3Results posted
- Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersCompletedNCT03190174Phase 1/2Results posted
- RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall ReconstructionCompletedNCT02228889Not applicableResults posted
- Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive FibromatosisCompletedNCT02066181Phase 3Results posted
- Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisCompletedNCT01981551Phase 2Results posted
- PAZOPANIB Efficacy and Tolerance in Desmoids TumorsCompletedNCT01876082Phase 2Results posted
- A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type FibromatosisCompletedNCT01265030Phase 1/2Results posted
- Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3Results posted
- Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasCompletedNCT00474994Phase 2Results posted
- Sulindac and Tamoxifen in Treating Patients With Desmoid TumorCompletedNCT00068419Phase 2Results posted
- Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)Active, not recruitingNCT07461246
- A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)Active, not recruitingNCT07170644Phase 2
- Electrochemotherapy for Desmoid TumorsWithdrawnNCT06660121
- PRISM for Depression and Anxiety in Young Adults With CancerCompletedNCT06502483Not applicable
- Burden of Disease and Living Situation in Desmoid PatientsCompletedNCT06258421
- CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid TumorsCompletedNCT06195085
- Cryoablation for Advanced and Refractory Desmoid TumorsStatus unknownNCT06113094
- A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid TumorStatus unknownNCT05561036Phase 3
- Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.Status unknownNCT05284305
- A Study of AL102 in Patients With Progressing Desmoid TumorsActive, not recruitingNCT04871282Phase 2/3
- Quality of Life of Patients With Desmoid-type FibromatosisCompletedNCT04289077
- A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by SurgeryActive, not recruitingNCT04195399Phase 2
- Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid FibromatosisCompletedNCT03966742Phase 2
- A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Active, not recruitingNCT03833700Phase 1
- A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid TumorCompletedNCT03802084Phase 1/2
- Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059CompletedNCT03459469Phase 1
- Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing SarcomaCompletedNCT03275818Phase 2
- Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor MalignanciesNo longer availableNCT02955446
- National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)Active, not recruitingNCT02867033Not applicable
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Optional Sub-study to Intraoperative Imaging With ICG RegistryCompletedNCT02651246
- HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid TumorsWithdrawnNCT02557854Phase 1
- Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor PatientsCompletedNCT02547831
- Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical TreatmentCompletedNCT02476305Not applicable
- 18F-FES PET/CT in Imaging Patients With Desmoid TumorsTerminatedNCT02374931Early Phase 1
- Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular TargetsStatus unknownNCT02353429Phase 2
- MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid TumorsCompletedNCT02076906Phase 1
- Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
- A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner SyndromeCompletedNCT01286662
- Endoxifen in Adults With Hormone Receptor Positive Solid TumorsCompletedNCT01273168Phase 1
- Study to Evaluate Imatinib in Desmoid TumorsCompletedNCT01137916Phase 2
- Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateCompletedNCT01046487Phase 1
- Effect of Hydroxyurea as Treatment for Primary Desmoid TumorsWithdrawnNCT00978146Phase 2
- Imatinib in Patients With Desmoid Tumor and ChondrosarcomaCompletedNCT00928525Phase 2
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaCompletedNCT00919269
- Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisCompletedNCT00287846Phase 1/2
- Radiation Therapy in Treating Patients With Aggressive FibromatosesCompletedNCT00030680Phase 2
- MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00020579Phase 1
- Vinblastine and Methotrexate in Treating Children With Desmoid TumorsCompletedNCT00003019Phase 2
- Toremifene in Treating Patients With Desmoid TumorsCompletedNCT00002595Phase 2